Answers are grounded in this paper and cite their sources.
Frailty summarizes aging-related decline independently of chronological age. Although the gut microbiome covaries with frailty in older populations, its causal contribution to frailty remains unclear. We profiled middle-aged (72-week-old) and young (10-week-old) male mice across six data layers including physio-behavioral phenotypes, fecal metagenomic taxa and pathways, serum lipidome, and liver and hippocampal transcriptomes. Aged mice exhibited elevated frailty, reduced motor coordination, and microbiome alterations, with members of Lactobacillus and Bacteroidia correlating with frailty. To assess microbiome dependence, we depleted the microbiome by late-life treatment with antibiotics or germ-free rearing from birth. With both, frailty in aged male mice shifted toward young-mouse values, but motor coordination and recognition memory did not, indicating selective microbiome regulation of aging phenotypes. Reduced frailty coincided with attenuated hepatic inflammatory signatures, including decreased expression of acute-phase reactants and altered fatty acid and bile acid metabolism. Microbiome depletion attenuated aging-associated lipidomic patterns, including reduced polyunsaturated-to-monounsaturated fatty acid ratio associated with diminished metabolic health. Multi-omics integration implicated lipoteichoic acid, microbial phytoestrogen metabolites, and reductions in immunomodulatory microbes in hepatic senescence, impaired bioenergetics, and inflammation. These findings suggest that the microbiome contributes to aging-induced frailty and provides new hypotheses for future mechanistic studies, including gut–liver regulation of immunometabolic function.
No takes yet. Share an insight, caveat, or question.
Chandra et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: